Lumere | Is MAKO’s cost justiﬁed by the clinical outcomes?

Is MAKO’s cost justiﬁed by the clinical outcomes?

MAKO from Stryker is a robotic orthopedic surgical system used in joint replacement surgeries to achieve highly accurate implant placement. Due to high acquisition and operating costs, health systems must weigh the clinical evidence before adopting this technology.

Download this article to:

View MAKO’s operational and clinical outcomes compared to manual surgery across three procedure types

Read our evidence-based adoption recommendations for this technology

Inform purchasing decisions on a $1M+ outlay

Evidence Insight Spotlight: MAKO from Stryker

Is MAKO’s cost justiﬁed by the clinical outcomes?